They have reported losing interest in a whole range of addictive and compulsive behaviors: drinking, smoking, shopping, biting nails, picking at skin. It was like a switch had flipped in her brain.Īs semaglutide has skyrocketed in popularity, patients have been sharing curious effects that go beyond just appetite suppression. For the first time-perhaps the first time in her whole life-all of her cravings and impulses were gone. The desire to drink, extinguished once, did not rush in as a replacement either. But most surprisingly, she walked out of Target one day and realized her cart contained only the four things she came to buy. (Colloquially, it is often referred to as Ozempic, though that is technically just the brand name for semaglutide that is marketed for diabetes treatment.) Her food thoughts quieted down. When she ran errands at Target, she would impulsively throw extra things-candles, makeup, skin-care products-into her cart.Įarlier this year, she began taking semaglutide, also known as Wegovy, after being prescribed the drug for weight loss. “I couldn’t stop from going to that extreme,” she told me. She would spend $500 on organic groceries, only to have them go bad in her fridge. After she got sober in her early 30s, she replaced drinking with food and shopping, which she thought about constantly. Sign up for it here.Īll her life, Victoria Rutledge thought of herself as someone with an addictive personality. Fink comes to the Main Line with his Philadelphia-born wife and two children.This article was featured in One Story to Read Today, a newsletter in which our editors recommend a single must-read from The Atlantic, Monday through Friday. His practice specialties include viral hepatitis, autoimmune liver disease, cirrhosis, end stage liver disease and liver transplantation, in addition to general gastroenterology.Ī native of New York City, Dr. Fink has presented original research at numerous national and international meetings and written many book chapters and articles on liver disease. Fink was director of the transplant hepatology fellowship training program at New York-Presbyterian.Ī nationally known specialist in liver disease and liver transplantation, Dr. He was on the faculty of the Columbia University College of Physicians and Surgeons and Weill Medical College of Cornell University and an attending physician at New York-Presbyterian Hospital’s Columbia University Medical Center and Weill Cornell Medical Center campuses from 2006-2011. A winner of the prestigious Advanced Hepatology Fellowship Award from the American Association for the Study of Liver Diseases, he underwent additional fellowship training in advanced liver disease and liver transplantation at New York-Presbyterian Hospital/Columbia University Medical Center. and his fellowship in Gastroenterology at Brigham and Women’s Hospital and Harvard Medical School. He went on to complete his internship and residency in Internal Medicine at The Mount Sinai Medical Center in New York, N.Y. Fink pursued a Master’s in Public Health at the Harvard School of Public Health. Scott Fink received his medical degree from New York University and his undergraduate degree at Cornell University.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |